|
|
|
Insider
Information: |
Watanabe Todd Franklin |
Relationship: |
See Remarks, Director |
City: |
Westlake Village |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
846,263 |
|
Indirect Shares
|
231,140 |
|
|
Direct
Value |
$7,751,769 |
|
|
Indirect Value
|
$2,117,242 |
|
|
Total
Shares |
1,077,403 |
|
|
Total
Value |
$9,869,011 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arcutis Biotherapeutics, Inc. |
ARQT |
See Remarks, Director |
2024-08-02 |
846,263 |
2024-08-02 |
231,140 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2022-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
268,964 |
382,907 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2024-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
264,882 |
891,901 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2024-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
627,019 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
99,964 |
478,447 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
70,900 |
663,526 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2023-12-01 |
4 |
OE |
$1.68 |
$100,038 |
D/D |
59,525 |
513,682 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2020-03-13 |
4 |
OE |
$1.68 |
$99,964 |
D/D |
59,481 |
566,928 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2020-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
49,981 |
49,981 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
598,916 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
507,447 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2024-03-04 |
4 |
AS |
$11.12 |
$165,739 |
D/D |
(14,903) |
874,533 |
0 |
% |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2024-08-02 |
4 |
AS |
$9.02 |
$130,648 |
D/D |
(14,487) |
846,263 |
0 |
% |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2024-05-02 |
4 |
AS |
$8.74 |
$120,433 |
D/D |
(13,783) |
860,750 |
0 |
% |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2022-07-08 |
4 |
AS |
$25.00 |
$342,473 |
D/D |
(13,500) |
651,871 |
0 |
% |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2023-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,126 |
502,019 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2023-12-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
13,126 |
24,413 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2021-01-05 |
4/A |
AS |
$28.08 |
$280,754 |
D/D |
(10,000) |
568,323 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2021-01-05 |
4/A |
OE |
$1.68 |
$16,806 |
D/D |
10,000 |
578,323 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2021-02-05 |
4 |
OE |
$1.68 |
$16,806 |
D/D |
10,000 |
578,323 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2021-02-05 |
4 |
AS |
$33.64 |
$342,916 |
D/D |
(10,000) |
568,323 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2021-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
7,377 |
57,358 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2022-07-08 |
4 |
OE |
$1.68 |
$11,910 |
D/D |
7,087 |
658,958 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
|
2023-03-02 |
4 |
AS |
$15.82 |
$86,606 |
D/D |
(5,472) |
369,092 |
0 |
% |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2020-09-29 |
4 |
OE |
$1.68 |
$5,042 |
D/D |
3,000 |
569,928 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
|
2020-09-29 |
4 |
AS |
$30.00 |
$90,000 |
D/D |
(3,000) |
566,928 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|